Financial Gravity Asset Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-72
Closed -$3.12K 1861
2024
Q1
$3.12K Sell
72
-363
-83% -$15K ﹤0.01% 977
2023
Q4
$15.5K Buy
435
+22
+5% +$790 ﹤0.01% 719
2023
Q3
$14.6K Buy
413
+377
+1,047% +$13.4K ﹤0.01% 568
2023
Q2
$8.93K Hold
36
0.02% 370
2023
Q1
$4.9K Buy
36
+1
+3% +$35 0.15% 154
2022
Q4
$9.55K Sell
35
-603
-95% -$20.1K 0.05% 264
2022
Q3
$4.61K Sell
638
-946
-60% -$35.9K 0.16% 130
2022
Q2
$11.5K Buy
1,584
+704
+80% +$38.9K 0.36% 55
2022
Q1
$6.21K Buy
880
+669
+317% +$36.3K 0.17% 125
2021
Q4
$3 Buy
+211
New +$11K ﹤0.01% 918
2021
Q3
Hold
0
652
2021
Q2
Hold
0
636
2021
Q1
Sell
-45
Closed -$2.04K 704
2020
Q4
$2K Buy
+45
New +$2.07K ﹤0.01% 319
2020
Q2
Sell
-126
Closed -$5.95K 371
2020
Q1
$5.95K Sell
126
-524
-81% -$28K 0.02% 315
2019
Q4
$72K Sell
650
-8
-1% -$445 0.05% 462
2019
Q3
$35K Buy
658
+19
+3% +$977 0.03% 349
2019
Q2
$32K Buy
639
+246
+63% +$12.3K 0.03% 401
2019
Q1
$21K Buy
+393
New +$19.6K 0.02% 432
2018
Q3
$23K Buy
476
+206
+76% +$10.5K 0.02% 454
2018
Q2
$14K Buy
270
+7
+3% +$353 0.01% 519
2018
Q1
$13K Buy
+263
New +$12.2K 0.01% 550

Other funds holding GSK

Financial Gravity Asset Management's GSK Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of GSK (GSK) in Q2 2024, closing a stake of 72 shares — an estimated $3.12K sold.

Financial Gravity Asset Management first reported a position in GSK in Q1 2018 and held it in 19 quarters. The position peaked at $72K in Q4 2019. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 72 GSK shares in Q2 2024, an estimated $3.12K.
  • Financial Gravity Asset Management first reported a position in GSK in Q1 2018 and held it in 19 quarters.
  • Financial Gravity Asset Management's GSK position peaked at $72K in Q4 2019.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.